Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase omega 3, pseudogene (GSTO3P) is a reverse-transcribed pseudogene located on human chromosome 3[2][8]. Unlike functional glutathione S-transferase omega (GSTO) enzymes, which catalyze the conjugation of glutathione to a wide variety of substrates for detoxification, GSTO3P does not produce a functional protein and is generally not transcribed or translated into an active enzyme. The functional omega class GSTs include GSTO1 and GSTO2, which have roles in cellular redox regulation, xenobiotic detoxification, and involvement in diseases, but GSTO3P, as identified by genomic investigations, represents a non-functional remnant of a gene in this family—no enzymatic or biological function has been attributed to it[2][3][8]. Because GSTO3P is a pseudogene and not an active enzyme, it is not considered a therapeutic, research, or biomarker target. Key clarifications: - This entry is not a functional protein and should not be listed as a drug target. - Its presence in genomics databases is for annotation and comparative genomics, not for therapeutic or clinical application[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase omega 3, pseudogene (GSTO3P).